2021
DOI: 10.1007/s10517-021-05301-5
|View full text |Cite
|
Sign up to set email alerts
|

Serum Serotonin as a Biomarker of the Efficacy of PAP-Therapy in Sleep Apnea Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Interestingly, the FSSQ has a sequence of questions concerning sleep apnea and snoring, which are relevant for assessing respiratoryrelated sleep alterations. Despite we did not detect OSA by HSAT, it was demonstrated that treatment of OSA by 3-month positive air pressure therapy (PAP) resulted in an enhancement of serum serotonin levels [34]. Considering the many roles of serotonin it is possible to conclude that low levels of serotonin might be linked with other changes seen in DFD patients besides sleep alterations, such as anxiety and depression.…”
Section: Discussionmentioning
confidence: 76%
“…Interestingly, the FSSQ has a sequence of questions concerning sleep apnea and snoring, which are relevant for assessing respiratoryrelated sleep alterations. Despite we did not detect OSA by HSAT, it was demonstrated that treatment of OSA by 3-month positive air pressure therapy (PAP) resulted in an enhancement of serum serotonin levels [34]. Considering the many roles of serotonin it is possible to conclude that low levels of serotonin might be linked with other changes seen in DFD patients besides sleep alterations, such as anxiety and depression.…”
Section: Discussionmentioning
confidence: 76%
“…Focusing on biomarkers like neurotransmitters such as serotonin (5-HT), which are crucial for health evaluation, , we developed our approach for the precise identification of target molecules. Serotonin plays an important roles in diseases affecting the cardiovascular system, causing carcinoid tumors, , or triggering diabetes mellitus. Research indicates that breast cancer cells release serotonin at concentrations of over 400 nM, which is 3 times higher than in normal cells . Lower 5-HT levels were also observed (about 5–10 nM) for type 2 diabetes .…”
Section: Introductionmentioning
confidence: 99%